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Abstract
Background: Emotion recognition dysfunction has been reported in both autism spectrum disorders (ASD) and
attention-deficit/hyperactivity disorder (ADHD). This suggests that emotion recognition is a cross-disorder trait that
may be utilised to understand the heterogeneous psychopathology of ASD and ADHD. We aimed to identify
emotion recognition subtypes and to examine their relation with quantitative and diagnostic measures of ASD and
ADHD to gain further insight into disorder comorbidity and heterogeneity.
Methods: Factor mixture modelling was used on speed and accuracy measures of auditory and visual emotion
recognition tasks. These were administered to children and adolescents with ASD (N = 89), comorbid ASD + ADHD
(N = 64), their unaffected siblings (N = 122), ADHD (N = 111), their unaffected siblings (N = 69), and controls (N = 220).
Identified classes were compared on diagnostic and quantitative symptom measures.
Results: A four-class solution was revealed, with the following emotion recognition abilities: (1) average visual,
impulsive auditory; (2) average-strong visual and auditory; (3) impulsive/imprecise visual, average auditory; (4) weak
visual and auditory. The weakest performing class (4) contained the highest percentage of patients (66.07%) and
the lowest percentage controls (10.09%), scoring the highest on ASD/ADHD measures. The best performing class (2)
demonstrated the opposite: 48.98% patients, 15.26% controls with relatively low scores on ASD/ADHD measures.
Conclusions: Subgroups of youths can be identified that differ both in quantitative and qualitative aspects of
emotion recognition abilities. Weak emotion recognition abilities across sensory domains are linked to an increased
risk for ASD as well as ADHD, although emotion recognition impairments alone are neither necessary nor sufficient
parts of these disorders.
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Background
Autism spectrum disorder (ASD) and attention-deficit/
hyperactivity disorder (ADHD) are highly comorbid, which is
likely due to shared aetiological mechanisms [1, 2]. Although
many models of the relationship between ASD, ADHD, and
their comorbidity have been hypothesised [2, 3], the inherent
heterogeneity within both diagnostic categories complicates
the study of the relationship between these disorders and
their developmental trajectories [4, 5]. Overlap has also been
noted in the cognitive deficits found in these disorders, in-
cluding emotion recognition dysfunction. This important as-
pect of social cognition has been reported as being impaired
in many disorders including ASD, ADHD, and disorders they
are comorbid with, such as depression and oppositional defi-
ant disorder (for a review see [6]).
For ASD, there is already a considerable body of litera-
ture regarding emotion recognition, for visual emotion
recognition abilities in particular, while this area of re-
search is relatively underdeveloped in ADHD. Nonethe-
less, studies of ASD and also ADHD have demonstrated
visual emotion recognition impairments for specific
emotions [7–17] and impairments for visually identifying
all emotions [18–29]. However, other studies did not re-
port impairments in recognising emotions at all [30–33].
Indeed, meta-analyses speak to the heterogeneity of vis-
ual emotion recognition performance in both ASD and
ADHD [34–36].
For auditory emotion recognition, the literature is less
advanced for both ASD and ADHD. Similar to visual
emotion recognition, this literature also demonstrates
inconsistent results, with auditory emotion recognition
in both ASD and ADHD suggested to be comparable to
controls [10, 17, 22, 24, 32, 37–39], worse than controls
[19, 23, 24, 40–42], or only worse for specific emotions
[12, 43–45].
Comparisons of emotion recognition impairments in ASD
and ADHD are scarce. Bora and Pantellis [34] indirectly
compared visual emotion recognition in ASD and ADHD
and suggested that impairments were present in ADHD, al-
though potentially milder than ASD. Only a handful of stud-
ies directly compared ASD and ADHD and occasionally
comorbid ASD+ADHD [8, 25, 40, 46–48]. Similar to the
findings for the disorders individually, the results of the
comparisons were also inconsistent, with ASD and ADHD
not demonstrating significant differences in emotion recog-
nition impairments [46, 48] or showing quantitative differ-
ences [40]. Berggren et al. [8] and Van der Meer et al. [47]
found overall differences in visual emotion recognition reac-
tion time, but not in accuracy between ASD (+ADHD) and
ADHD. Therefore, to what extent emotion recognition im-
pairments are similar and/or unique in ASD and ADHD is
still largely unknown due to these heterogeneous results.
Previous research has demonstrated that empirical sub-
typing is a valuable tool for improving our understanding
of ASD and ADHD [4, 5, 49–51]. Techniques that
explicitly utilise heterogeneity, as observed for emotion
recognition abilities in ASD and ADHD, can be used to
optimally investigate overlap and differences between
disorders. In our previous study [48], we identified a factor
structure of emotion recognition that underlies ASD and
ADHD, which can serve as a useful basis to identify
homogeneous subgroups. Factor mixture modelling
(FMM) can be used for this and is a logical extension of
factor analysis, as it combines factor analysis with latent
class analysis. It therefore allows the data to be viewed
from categorical, person-based perspectives, and dimen-
sional, variable-based perspectives simultaneously. This
modelling technique can identify homogeneous subgroups
without a-priori specifications, the use ofclass probabilities
allows for classes with subtle differences to be identified,
statistics determining the goodness-of-fit can be used to
determine the most appropriate model and independence
of participants is not an issue because family structures
can be taken into account. In this way, FMM has advan-
tages over other clustering methods, such as hierarchical
clustering and community detection [52–54].
Consequently, the current study aimed to investigate
the heterogeneity of emotion recognition in individuals
with neurodevelopmental disorders ASD and ADHD,
and its potential as a transdiagnostic phenotype by iden-
tifying emotion recognition subtypes with FMM. The
emotion recognition data was reduced to underlying,
continuously distributed factors that drive performance
on emotion recognition tasks (as identified in Wadding-
ton et al. [48]). These factors were then used to create
homogeneous subgroups of participants that have very
similar emotion recognition profiles. By including pa-
tients with ASD, ADHD, and ASD +ADHD, unaffected
siblings of ASD and ADHD patients, and healthy con-
trols, we covered the entire spectrum from low risk
(controls) to moderate risk (unaffected siblings) and high
risk (patients) for emotion recognition dysfunction. The
FMM-based emotion recognition subgroups were com-
pared on their diagnostic (ASD, ADHD) and quantitative
symptom profiles (autism symptom severity, inattention,
hyperactivity/impulsivity, oppositional behaviour, anx-
iety) to examine how emotion recognition dysfunction
relates to (cross-disorder) symptoms. To our knowledge,
this is the first study to directly compare pure and co-
morbid ASD and ADHD on emotion recognition deficits
and the role of ASD and ADHD behavioural symptoms,
whilst accounting for heterogeneity.
Methods
Participants
The data used in this study originally came from two co-
horts, the NeuroIMAGE study, which is a follow-up
(2009–2012) of the Dutch part of the International
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Multicenter ADHD Genetics (IMAGE) study performed
between 2003 and 2006 [55–58] and the Biological Ori-
gins of Autism (BOA) study [59]. In these cohort stud-
ies, the recruited patient families were included if (1)
they had one child with a clinical diagnosis of ADHD
(NeuroIMAGE) or ASD (BOA) and (2) at least one bio-
logical sibling (regardless of possible clinical diagnosis)
willing to participate. Healthy control families had at
least one child, with no formal or suspected ADHD or
ASD in the participant or any first-degree relatives. All
participants were of European Caucasian descent. In
both cohorts, the exclusion criteria were an IQ < 70, a
diagnosis of epilepsy, brain disorders, known genetic dis-
orders (e.g. down syndrome or fragile X syndrome), with
an additional criterion of a clinical diagnosis of autistic
disorder or Asperger disorder in the NeuroIMAGE co-
hort. For the current study, a subsample of participants
was selected from both cohorts, which was matched on
mean chronological age (M = 12.6 years, SD = 2.4, age
range 7–18 years; see Additional file 1: Figure S1 and
Table S4 for details). The number of comorbid ASD +
ADHD unaffected siblings was relatively small, and sub-
sequently, these unaffected siblings were grouped with
the ASD-unaffected siblings. In total, 89 participants
with ASD (further mentioned as ASD-only patients), 64
participants with comorbid ASD + ADHD (further men-
tioned as ASD + ADHD patients), 122 of their unaffected
siblings, 111 patients with ADHD (further mentioned as
ADHD-only patients), 69 of their unaffected siblings,
and 220 healthy controls were included. The BOA data
used in this study partly overlaps (79%) with a previous
study [12].
Diagnostic assessment
All participants were phenotyped for ASD and ADHD
using validated and standardised questionnaires and diag-
nostic interviews. Briefly, children already clinically diag-
nosed with ASD and/or ADHD, their siblings, and the
control children were screened for the presence of ASD
and ADHD symptoms using the parent-reported Social
Communication Questionnaire (SCQ) [60] and the par-
ent- and teacher-reported Conners Rating Scales—Revised
(CPRS and CTRS respectively) [61]. Raw scores of ≥ 10 on
the SCQ total score and T scores ≥ 63 on the Conners
DSM-IV inattention, hyperactivity-impulsivity, or com-
bined scales were considered as potential clinical cases.
All youth scoring above cutoff on any of the screening
questionnaires underwent full clinical ADHD assessment
using the Parental Account of Childhood Symptoms
ADHD subversion (PACS) for ADHD (BOA cohort) [62]
or the Schedule for Affective Disorders and Schizophre-
nia for School-Age Children—Present and Lifetime
Version (K-SADS; in NeuroIMAGE) [63]. Clinical as-
sessment for ASD was performed using the Autism
Diagnostic Interview-Revised (ADI—R) structured inter-
view for ASD (BOA cohort) [64]. Control youth were re-
quired to obtain non-clinical scores (i.e. a raw score < 10
on the SCQ and T score < 63 on both CPRS and CTRS) to
qualify for this study (further details in Additional file 1).
Cognitive measures
Emotion recognition
Speed (mean reaction time) and accuracy (percentage of
errors) of visual and auditory emotion recognition were
measured using the Identification of Facial Emotions
(IFE) task and the Affective Prosody (AP) task from the
battery of the Amsterdam Neuropsychological Tasks
(ANT) [65]. In the IFE task, participants viewed individ-
ual photos of facial expressions and indicated if they saw
the target emotion (happy, fearful, or angry) in these
photos (Additional file 1: Figure S1). In the AP task, par-
ticipants listened to sentences of neutral content that
differed in prosody. The participants had to identify the
emotion (happy, fearful, sad, or angry) of the voice they
heard. Both tasks are fully described elsewhere [12].
Intelligence
An estimate of the Full-Scale Intelligence Quotient (FSIQ)
was derived from two subtests (Vocabulary and Block De-
sign) of the Wechsler Intelligence Scale for Children version
III (WISC-III) [66] for participants younger than 16 years or
the Wechsler Adult Intelligence Scale version III (WAIS-III)
[67] for participants 16 years and older.
Procedure
The tasks described were part of broader assessment
batteries used in the BOA and NeuroIMAGE cohorts.
Testing was conducted in quiet rooms with minimal dis-
tractions. Participants were asked to withhold use of
psychoactive drugs for at least 24 h before measurement.
During the testing day, participants were motivated with
short breaks, and at the end of the day, the children
were rewarded. Both studies were approved by the local
medical ethics board. Written informed consent was ob-
tained from all participants and their parents (parents signed
informed consent for participants under 12 years of age).
Analyses
SPSS version 22 was used for the analysis of the data.
Less than 5% of the data was missing. Data was imputed
for each cohort separately using SPSS based on the data
from the IFE and AP tasks as well as gender, age, IQ,
and family and diagnostic status. The measures for both
cohorts together were normalised and standardised
using Van der Waerden transformation, and the IQ scor-
ing was reversed. Consequently, all of the variables had
scores on the same z scale, with lower scores implying
better performance (fewer errors, faster reaction times,
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and a higher IQ). Standardised age-regressed residuals
were calculated.
The model-fitting analyses were performed using MPlus
version 6 [68]. The stepwise FMM strategy suggested by
[52] was used on the combined cohorts, using the models
derived from less demanding techniques (i.e. confirmatory
factor analysis (CFA), latent class analysis (LCA)) as input
for the more complex FMM estimation process. The follow-
ing four factors underlying the 14 emotion recognition vari-
ables from the previous factor analysis of this sample [48]
were used: visual speed, visual accuracy, auditory speed, and
auditory accuracy. As the next step, LCA was conducted on
the four factors to explore how many classes could be distin-
guished. Subsequently, we conducted the FMM, using the
models derived from CFA conducted in Waddington et al.
[48] and LCA to guide model fitting. For all stages of the
LCA and FMM, the model fit was assessed using the Akaike
information criteria (AIC), Bayesian information criteria
(BIC), Lo-Mendell-Rubin test, and entropy. The details of
criterion for adequate fit and the results of the models can
be found in the Additional file 1: Tables S1–S3.
Mixed models were used to assess the differences be-
tween the classes on scores for the emotion recognition fac-
tors, speed-accuracy trade-offs in the visual and auditory
domains, as well as gender, age, IQ, and phenotypic mea-
sures. Additionally, chi-square tests were performed to as-
sess differences in diagnostic proportions between the
classes. Multiple comparisons were corrected according to
the false discovery rate (FDR) controlling procedure, with
the q value set at .05. Post hoc analyses comparing patients
and controls separately across classes were conducted to as-
sess if different emotion recognition subtypes within diag-
nostic groups were related to symptoms. A comprehensive
overview of the results of the mixed models and T tests can
be found in the Additional file 1: Tables S5–S6.
Results
Utilising the four-factor solution (visual speed, visual accur-
acy, auditory speed, and auditory accuracy) identified in
Waddington et al. [48] for this sample, four classes were
suggested in the LCA. A four-factor four-class solution was
therefore used as an initial criterion to guide the fitting of
the FMM, which had an optimal fit for the data (see Add-
itional file 1 for details). The classes were labelled according
to the characteristics of their emotion recognition profiles
(Fig. 1, Additional file 1: Tables S4–S6). Class 4 (n = 149)
was the worst-performing class, demonstrating weaknesses
on both visual and auditory emotion recognition. This class
was significantly slower and less accurate than the other
classes across visual and auditory emotion recognition, with
the exception of class 3 on visual accuracy. Comparing mo-
dalities within class 4, participants were significantly faster
and more accurate at visual than auditory emotion recogni-
tion (visual versus auditory speed: pFDR < .001, d = 0.77;
visual versus auditory accuracy: pFDR = .004, d = 0.48). Class
2 (n = 303) was an average-performing class, having average
to strong visual and auditory emotion recognition abilities,
relative to the other classes. This class was faster and more
accurate than class 4 in both visual and auditory emotion
recognition. Class 2 also showed signs of a speed-accuracy
trade-off, favouring accuracy over speed (visual speed ver-
sus visual accuracy: pFDR < .001, d = 0.98; auditory speed
versus auditory accuracy: pFDR < .001, d = 2.00). Classes 1
and 3 can be referred to as an impulsive auditory, average
visual emotion recognition class and an impulsive and im-
precise visual, average auditory emotion recognition class,
respectively. Class 1 (n = 173) showed significant
speed-accuracy trade-offs, trading both visual and auditory
accuracy in favour of speed, strongest for auditory recogni-
tion (visual speed versus visual accuracy: pFDR = .001, d =
0.51; auditory speed versus auditory accuracy: pFDR < .001,
d = 5.84). Class 3 had a greater speed-accuracy trade-off in
visual emotion recognition: pFDR < .001, d = 13.87) than
auditory emotion recognition: pFDR = .003, d = 0.88). The
inclusion of age, sex, and IQ covariates did not attenuate
these effects.
The four identified classes differed in IQ (F(3, 671) =
15.17, pFDR < .001, d = 0.24) and sex (F(3, 671) = 5.33,
pFDR = .002, d = − 0.30), but not in age (F(3, 671) = 1.83,
pFDR = .14 d = − 0.05). Class 4 had a significantly lower
IQ than the other classes (class 4 versus class 1: pFDR
< .001, d = 0.43; class 4 versus class 2: pFDR < .001, d =
0.40; class 4 versus class 3: pFDR = .006, d = 0.45). The
proportion of males did not differ significantly between
the classes (see Additional file 1: Table S7).
Sex and IQ affected the individual factors differentially. Sex
and IQ only affected accuracy factors (visual—sex:
F(1, 675) = 7.27, pFDR = .028, d = 0.02; IQ: F(1, 675) = 5.14,
pFDR = .048, d = 0.02; auditory—sex: F(1, 675) = 9.20,
pFDR = .006, d = − 0.21; IQ: F(1, 675) = 28.19, pFDR = .006,
d = − 0.36), but not visual or auditory speed.
Behavioural and diagnostic profiles of the classes
As shown in Fig. 2 and Additional file 1: Table S7, when test-
ing dimensional measures of ASD- and ADHD-related be-
haviour, class 1 had lowest symptom levels for ASD, ADHD,
and related behaviours, whereas class 4 had the highest.
These classes significantly differed in all symptom domains
(pFDRs < .001–.017, d’s = 0.27–0.50) with the exception of
oppositional behaviour (p= .07). Similarly, class 4 also dif-
fered significantly from class 2 on almost all measures of
ASD, ADHD, and comorbid symptoms (pFDRs < .003–.024,
d’s = 0.23–0.30) except for oppositional symptoms (p= .07)
and fear of changes (p= .08). Class 1 and 2 differed in several
ASD symptoms. Class 3 did not differ significantly from any
of the classes, potentially due to the small sample size.
The pattern of results did not change, when age, sex,
and IQ were accounted for, but the significance of the
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majority of these class differences was attenuated
(Additional file 1: Table S7). Class 1–class 4 differences
in two CSBQ items remained significant (not tuned in:
pFDR = .002, d = 0.34; Tendency to withdraw: pFDR = .002,
d = 0.35).
Diagnostic profiles of members of the classes are given
in Fig. 1, which provides weighted percentages to ac-
count for differences in the numbers of participants in
the diagnostic groups. Pure and comorbid ASD and
ADHD patients, their unaffected siblings, and controls
all were present in every class. The average to strong
performing classes (classes 1 and 2) consisted of 28.3%
and 15.3% controls, respectively, class 3 had 10.9%
controls, but also the weakest performing class (class 4)
contained 10.1% of controls. With regard to patients,
class 4 consisted of 25.1% ASD +ADHD patients, 17.2%
ASD-only patients, and 23.8% ADHD-only patients.
Class 1 contained 11.4% ASD + ADHD patients, 9.0%
ASD-only patients, and 15.2% ADHD-only patients.
Similarly, class 2 also had substantial proportions of pa-
tients, with 16.5% ASD +ADHD patients, 19.3%
ASD-only patients, and 13.2% ADHD-only patients.
Nonetheless, within-class proportions comparison showed
that only class 1 had significantly more controls than
ASD +ADHD patients (X2(1) = 7.41, pFDR = .045, d = 0.68)
and ASD-only patients (X2(1) = 9.76, pFDR = .03, d = 0.76)
after FDR correction (Additional file 1: Table S8).
How do patients with and without emotion recognition
impairments differ?
To examine how patients with and without emotion recogni-
tion impairments diverged in their symptoms, post hoc ana-
lyses comparing the patients from class 4 with those from
the best performing classes 1 and 2 were performed. Again,
in these analyses, the phenotypic profiles of classes were
compared using mixed models and corrected for age and
familial effects. ASD+ADHD, ASD-only, and ADHD-only
patients in classes 4, 1, and 2 did not significantly differ in
ASD- orADHD-related symptom scores (seeAdditional file 1:
Figure S2). These results did not change when age, sex, and
IQ were accounted for.
Discussion
In this study, we aimed to investigate emotion recognition
as a transdiagnostic phenotype in order to understand the
heterogeneity and comorbidity of ADHD and ASD. We
did so by identifying emotion recognition subtypes in pure
and comorbid ASD and ADHD patients, their unaffected
Fig. 1 Box: emotion recognition classes identified in the current study across patients with pure and comorbid ASD and ADHD, their unaffected siblings,
and controls. Each line represents the emotion recognition profile (mean factor scores − speed and accuracy of IFE and AP tasks ± 1 S.E.) for each class.
Lower scores represent faster reaction time and fewer errors made. An age covariate was applied. Lower panel: pie charts represent the within-class
weighted proportions of each diagnostic group. For each class, diagnostic groups were weighted using a weighting coefficient of %within diagnostic
group/% within-class. Right panel: pie charts represent the proportion of each diagnostic group across each class
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siblings, and healthy controls. This was done using FMM,
which is powerful in integrating variable-based data re-
duction (factor analysis) with a person-based identification
of qualitatively different subtypes (latent class analysis).
We explored whether the identified subtypes provide
insight into the heterogeneity and comorbidity of ASD
and ADHD. Analyses revealed four groups of participants:
an average to strong performing class with reasonably fast
and accurate performance across visual and auditory do-
mains (class 2), a class with impulsive auditory recognition
yet reasonably fast and accurate in their visual emotion
recognition (class 1), a poor performing class with slow
and inaccurate performance across both domains (class
4), and an intermediate class with a large speed-accuracy
trade-off in the visual domain (class 3). None of the identi-
fied classes or related emotion recognition impairments in
either modality were particularly linked to ASD or ADHD.
All classes contained patients from all three diagnostic
categories (ASD-only, ADHD-only, and ASD +ADHD) as
well as their unaffected siblings and controls. Emotion
recognition impairments were similarly frequent in ASD
as in ADHD and ASD +ADHD, with 17.2% of ASD pa-
tients, 23.8% of ADHD patients, and 25.1% of patients
with comorbid ASD and ADHD falling into the weakest
performing class. At the level of quantitative measures of
disease-related behaviour, the relationship between the two
ADHD symptom domains inattention vs hyperactivity/im-
pulsivity and class status was comparable, indicating emo-
tion recognition problems linked similarly to both ADHD
symptom domains. There was a clear enrichment of ASD-
and ADHD-related symptoms seen in the
worst-performing class 4. However, post hoc tests demon-
strated that although these symptoms are associated with
emotion recognition impairments, there is certainly no
one-to-one relationship.
The poorest performing emotion recognition class
(class 4) differed from the two good/average performing
classes (classes 1 and 2) in quantitative measures, with
higher levels of ASD, ADHD, and comorbid symptoms
being present in class 4. Previous studies [12, 26] sug-
gested that behavioural symptoms, such as inattention,
are important contributors to emotion recognition dys-
function. Our results partially support this notion, given
that higher levels of ASD, ADHD, and comorbid symp-
toms were present in the weakest performing class. Yet,
the pure and comorbid ASD and ADHD patients in the
strong to average performing classes (classes 1 and 2)
did not differ significantly in quantitative measures of
ASD and ADHD symptoms compared to the weakest
class (class 4), indicating that the relationship between
ASD and ADHD behavioural symptoms and emotion
recognition dysfunction is not 1:1. Furthermore, our
findings speak to the presence of cognitive heterogeneity
in both ASD and ADHD, which corroborates previous
findings of multiple developmental pathways in ADHD
[4, 50] and ASD [5, 69]. Moreover, none of the identified
emotion recognition subtypes were specific to ASD or
ADHD, neither in symptoms nor in diagnosis. This lack
Fig. 2 Class profiles of IQ and ASD, ADHD, and comorbid symptoms. Each bar represents the mean z score (± 1 S.E.) for ADHD symptoms
from Conners’ Parents Rating Scale (CPRS), Conners’ Teachers Ratings Scale (CTRS), and the Children’s Social Behaviour Questionnaire
(CSBQ). IQ z scores were reversed (higher IQ z score = lower IQ). One asterisk indicates the significant difference between classes 1 and 4.
Two asterisks indicate the significant differences between classes 1 and 4 or classes 2 and 4. Three asterisks indicate the significant
differences between class 4 and classes 1, 2, and 3
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of specificity, combined with observed associations with
comorbid symptoms, suggests that emotion recognition
dysfunction is a trait that can be utilised to understand
the co-occurrence of other disorders that are frequently
comorbid with ASD and ADHD (e.g. bipolar disorder,
anxiety disorders, conduct disorder) and that are also
marked by emotion recognition dysfunction [6].
Despite the commonalities in findings for emotion
recognition problems in relation to both quantitative
ASD and ADHD symptom measures as well as diagnos-
tic/categorical measures, it is possible that the mecha-
nisms underlying poor emotion recognition in ASD and
ADHD differ. For example, individuals with ASD allo-
cated to the weakest emotion recognition class may have
a primary emotion recognition deficit, whereas individ-
uals with ADHD allocated to the same class might have
more general information processing difficulties, with
emotion recognition problems being secondary to that.
To address this issue, mechanistic measures are needed,
foremost functional brain activation whilst performing
emotion recognition tasks. Unfortunately, in the current
study, these data were not available. However, even if
underlying mechanisms contributing to a poor emotion
recognition performance may be partly dissimilar in in-
dividuals with ASD and ADHD, the end result is that on
a performance level, a large proportion of individuals
with ADHD performs on the worst level as measured by
the tasks administered in this study. This likely trans-
lates to social difficulties in daily life, where a poor regis-
tration of emotional expressions of other people
(whether due to primary emotion recognition difficulties
or secondary general information processing difficulties)
is likely to interfere with social interaction. In conclu-
sion, although functional brain imaging measures are
needed to shed light on the issue of (non-) overlapping
mechanisms underlying poor emotion recognition in in-
dividuals with ASD and ADHD, on a performance level,
much similarities are observed with poor emotion recog-
nition abilities present in a substantial proportion of in-
dividuals with ASD and ADHD alike.
This study demonstrates the benefits of utilising a
model-based approach to gain insight into the comor-
bidity of disorders, in this case, ASD and ADHD. Our
model suggests that emotion recognition dysfunction
may not be a feature that distinguishes between ASD
and ADHD. Previous literature has shown emotion rec-
ognition to be a plausible endophenotype [12, 48] and
that the development of social cognition is suggested to
be functionally dependent on the maturation of cogni-
tive skills, and possibly vice versa [47, 70, 71]. Therefore,
our findings, combined with current literature, could in-
dicate support for models like the step-endophenotype
framework [5]. This model poses that below a certain
threshold, an individual’s risk is low; yet, once a
threshold has been reached, the risk markedly increases.
In this case, it may be hypothesised that—similar to cog-
nitive dysfunction—emotion recognition dysfunction
only increases the likelihood of neurodevelopmental
symptoms and disorders in combination with other risk
factors and/or after a certain threshold has been
exceeded. However, much remains to be investigated re-
garding this relationship between emotion recognition,
these neurodevelopmental disorders and their symp-
toms, as well as other risk factors. The identified sub-
types may differ in neural correlates, genetics, and their
developmental trajectories, which may affect their re-
sponse to treatment. Studies including longitudinal de-
signs are required to further clarify the role of emotion
recognition in its effects on developmental
psychopathology.
This study has several strengths, including the use of
both categorical and dimensional measures of psycho-
pathology and analyses, employing validated emotion
recognition paradigms, and the inclusion of a large sam-
ple size containing patients, unaffected siblings, and con-
trols. This has enabled comparisons of both quantitative
and qualitative differences in emotion recognition im-
pairments across ASD and ADHD and the assessment of
the heterogeneity of such impairments across the entire
breadth of the symptom distribution. However, even
with our large sample size, the least prevalent class (class
3) reached only a limited size. For this class, power was
limited to investigate links to diagnostic status and
quantitative behavioural measures. This study was also
limited by the type of emotion recognition tasks used.
Although these tasks have been validated [65], they as-
sess visual and auditory emotion recognition separately.
Future studies of simultaneous visual and auditory emo-
tion recognition could provide more insight into multi-
modal emotion processing abilities. Another potential
limitation of our study was that all of our participants
had an IQ higher than 70, limiting the generalisability of
the results to individuals with an IQ below 70. IQ also
significantly differed between subtypes, with the
average-strong performing classes (classes 1 and 2) hav-
ing higher IQs. Furthermore, IQ was associated with the
accuracy of emotion recognition, corroborating with re-
ports that IQ and emotion recognition abilities are inter-
twined [72, 73]. However, controlling for IQ differences
did not alter the findings, indicating that class differ-
ences were not driven by overall cognitive performance
differences. The male to female ratio was more balanced
in the group of individuals with ADHD than it was in
the group of individuals with ASD. However, since re-
sults were analysed with gender-corrected means, it is
unlikely that this has influenced the outcome of the
clustering analysis. Although we used FMM because of
its many advantages, there are other methodologies that
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can investigate the heterogeneity of these disorders. For
example, Lombardo et al. [74] used hierarchical cluster-
ing of participants patterns of response on the Reading
the Minds Eye Test (RMET) to understand the hetero-
geneity of metalizing in ASD and typically developing
participants. This study found response patterns specific
to ASD subgroups and other response patterns specific
to typically developing participants. Though this was not
the aim of the current study, elucidating diagnostic spe-
cific response patterns are potentially informative of
diagnostic differentiating factors. As such, the advan-
tages and disadvantages of each modelling technique
should be considered in relation to the aims of a study.
The findings of this study have clear clinical implica-
tions. Emotion recognition dysfunction cannot be used
either to confirm or disconfirm the presence of ASD
and/or ADHD. However, this does not mean that emo-
tion recognition impairments should not be assessed
and treated when necessary in both ASD and ADHD. As
demonstrated, emotion recognition impairments are at
least as important in ADHD as they are in ASD, particu-
larly as these impairments show links to cognitive func-
tioning and are likely to contribute to emotion
dysregulation, both of which can be identified in ASD
and ADHD. Therefore, for some individuals with ASD
and/or ADHD, the inclusion of emotion recognition
skills training could be highly beneficial.
Conclusions
This study identified emotion recognition subtypes in
patients with pure and comorbid ASD and ADHD, their
unaffected siblings, and healthy controls using FMM.
Emotion recognition dysfunction behaves as a risk factor
for developing ASD and/or ADHD, although heterogen-
eity of impairments across clinical groups and controls
clearly shows that there is no 1:1 relationship with ASD
and/or ADHD symptoms. The observed classes with dif-
ferential emotion recognition profiles warrant further in-
vestigation, as they could differ in neural correlates and
genetics, and prognosis may be different. We conclude
that emotion recognition dysfunction should be consid-
ered when assessing and treating both ASD and ADHD,
demonstrating the need to broadly assess an individual’s
strengths and weaknesses to provide optimal care.
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